Jinxin Fertility Group Limited (HKG:1951)
2.860
+0.020 (0.70%)
Sep 30, 2025, 4:08 PM HKT
Jinxin Fertility Group Revenue
Jinxin Fertility Group had revenue of 1.29B CNY in the half year ending June 30, 2025, a decrease of -3.40%. This brings the company's revenue in the last twelve months to 2.66B, down -8.36% year-over-year. In the year 2024, Jinxin Fertility Group had annual revenue of 2.81B with 0.81% growth.
Revenue (ttm)
2.66B CNY
Revenue Growth
-8.36%
P/S Ratio
2.68
Revenue / Employee
830.65K CNY
Employees
3,198
Market Cap
7.79B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2.81B | 22.69M | 0.81% |
Dec 31, 2023 | 2.79B | 424.43M | 17.95% |
Dec 31, 2022 | 2.36B | 525.65M | 28.59% |
Dec 31, 2021 | 1.84B | 412.74M | 28.94% |
Dec 31, 2020 | 1.43B | -222.41M | -13.49% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
BeOne Medicines AG | 35.81B |
Hansoh Pharmaceutical Group Company | 14.45B |
JD Health International | 71.34B |
WuXi Biologics | 21.98B |
Innovent Biologics | 12.52B |
Sino Biopharmaceutical | 33.49B |
Akeso | 2.75B |
Sichuan Kelun-Biotech Biopharmaceutical | 1.64B |